NCT07738406

Brief Summary

This study aims to evaluate the clinical efficacy and safety of an intelligent robotic system for the closed reduction of extra-articular supracondylar femoral fractures (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 33-A). Traditional manual reduction for supracondylar femoral fractures is often challenging due to strong muscle pull, heavily relying on the surgeon's experience and frequently requiring repeated fluoroscopy. This clinical trial compares robot-assisted closed reduction against traditional surgeon-led reduction methods. The primary goal is to determine if the robotic system improves the precision of bone alignment (excellent and good reduction rate) and functional recovery while reducing surgical radiation exposure.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
29mo left

Started Jul 2026

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress3%
Jul 2026Dec 2028

Study Start

First participant enrolled

July 1, 2026

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

July 8, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 31, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

July 31, 2026

Status Verified

July 1, 2026

Enrollment Period

1.5 years

First QC Date

July 8, 2026

Last Update Submit

July 28, 2026

Conditions

Keywords

Fracture FixationRobotic Surgical ProceduresMinimally Invasive Surgical ProceduresAnatomic Reduction StandardArtificial Intelligence

Outcome Measures

Primary Outcomes (1)

  • Rate of Excellent or Good Closed Fracture Reduction Assessed by Postoperative Low-Dose CT-Based 3D Quantitative Reduction Grading Criteria

    The percentage of patients achieving "Excellent" or "Good" anatomical closed reduction. Reduction quality is measured on post-op CT via RadiAnt DICOM Viewer and 3D Slicer based on the worst-performing of 3 dimensions: 1. Separation/shortening displacement: Excellent (≤3mm), Good (\>3-5mm), Fair (\>5-10mm), Poor (\>10mm). 2. Angulation deformity: Excellent (≤3°), Good (\>3-5°), Fair (\>5-10°), Poor (\>10°). 3. Rotational deformity: Excellent (≤3°), Good (\>3-5°), Fair (\>5-10°), Poor (\>10°). The final reduction grade is determined by the lowest category among these parameters, and the primary outcome represents the proportion of patients graded as Excellent or Good.

    From completion of surgery to postoperative low-dose CT assessment, assessed up to 2 weeks after surgery

Secondary Outcomes (14)

  • Total Operation Time Measured in Minutes

    From initial skin incision to completion of skin closure, assessed up to 8 hours

  • Number of Intraoperative C-Arm Fluoroscopy Shots

    From initial skin incision to completion of skin closure, assessed up to 8 hours

  • Intraoperative Blood Loss Measured in Milliliters

    From initial skin incision to completion of skin closure, assessed up to 8 hours

  • Length of Hospital Stay Measured in Days

    From hospital admission to hospital discharge, assessed up to 30 days

  • Robot-Assisted Reduction Planning and Execution Time Measured in Minutes in the Experimental Group

    From initial skin incision to completion of the reduction maneuver, assessed up to 8 hours

  • +9 more secondary outcomes

Study Arms (2)

Robot-Assisted Group

EXPERIMENTAL

Automated/human-robot collaborative closed fracture reduction powered by an intelligent robotic system, followed by distal femoral locking plate fixation via MIPO technique

Device: Robot-assisted closed reduction

Traditional Group

ACTIVE COMPARATOR

Conventional closed or open fracture reduction performed entirely by the surgical team under ordinary C-arm fluoroscopy, followed by standard fixation (plates or intramedullary nails)

Device: Conventional fracture reduction and internal fixation

Interventions

The patient undergoes automated or human-robot collaborative closed fracture reduction powered by an intelligent robotic system. The system integrates deep-learning-based bone segmentation, automatic reduction planning, and a self-adaptive 2D-3D image registration framework to achieve sub-millimeter positioning feedback and force-position collaborative security gates. Following successful reduction, internal fixation is performed using a distal femoral locking compression plate (LCP-DF) via the minimally invasive percutaneous plate osteosynthesis (MIPO) technique.

Robot-Assisted Group

The patient undergoes conventional closed or open fracture reduction performed entirely by the surgical team based on traditional clinical experience under ordinary C-arm fluoroscopic guidance. Internal fixation is achieved using standard distal femoral locking plates or intramedullary nails (with dual-plate fixation permitted when indicated for medial bone defects or collapse) according to the surgeon's choice and standard of care.

Traditional Group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 80 years old
  • Unilateral, acute, closed extra-articular supracondylar femoral fracture (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 33-A)
  • Time from injury to surgery ≤21 days
  • Able to walk independently before injury (assistive devices allowed)

You may not qualify if:

  • Open fractures or multiple severe traumas requiring priority treatment
  • Asymmetrical lower extremities, or prior malunion of the ipsilateral femur, or pre-existing deformities significantly affecting rotation/length evaluation
  • Unilateral fractures combined with other sites
  • Pathological fractures (tumor or metabolic)
  • Prior complex implants in place or previous surgeries significantly affecting evaluation
  • Active infection or severe systemic medical contraindications (unable to tolerate anesthesia/surgery)
  • Cognitive impairment, poor compliance, pregnancy, or lactation
  • Deemed unsuitable by the investigator (e.g., unable to follow up, or extreme obesity severely limiting the surgical or robotic workspace)
  • Refused randomization or enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Aerospace Center Hospital

Beijing, Beijing Municipality, 100035, China

RECRUITING

Beijing Jishuitan Hospital

Beijing, Beijing Municipality, 100035, China

RECRUITING

MeSH Terms

Conditions

Femoral Fractures

Interventions

Fracture Fixation, Internal

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesLeg Injuries

Intervention Hierarchy (Ancestors)

Fracture FixationOrthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Central Study Contacts

Chunpeng Zhao, MD / Chief Physician

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 8, 2026

First Posted

July 31, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

July 31, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations